Probiotics as a therapeutic strategy for metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.
- 2025-07-25
- Review · n = 657
- Current research in food science 11
- Jing Lu
- Xiaoxiao Dong
- Ziqi Gao
- Huizhen Yan
- Dilireba Shataer
- Liang Wang
- Yanan Qin
- Minwei Zhang
- Jiayi Wang
- Jie Cui
- Shengyang Zhou
- PubMed: 40697756
- DOI: 10.1016/j.crfs.2025.101138
- High evidence
Compared with placebo, probiotics significantly reduced liver-related measures, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyl transaminase (GGT) levels
- Beneficial
- Moderate effect
- Significant